Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Yuko Nishinaga"'
Autor:
Kazuomi Takahashi, Shunichi Taki, Hirotoshi Yasui, Yuko Nishinaga, Yoshitaka Isobe, Toshinori Matsui, Misae Shimizu, Chiaki Koike, Kazuhide Sato
Publikováno v:
Cancer Medicine, Vol 10, Iss 24, Pp 8808-8819 (2021)
Abstract Background Human epidermal growth factor receptor 2 (HER2) is tyrosine kinase receptor that belongs to the ErbB family and is overexpressed on the membrane surface of various cancer cells, including small cell lung cancer (SCLC); however, no
Externí odkaz:
https://doaj.org/article/1d8e6e68951c4d549c4a7ae0b18eb9dd
Autor:
Shunichi Taki, Kohei Matsuoka, Yuko Nishinaga, Kazuomi Takahashi, Hirotoshi Yasui, Chiaki Koike, Misae Shimizu, Mitsuo Sato, Kazuhide Sato
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 11 (2021)
Externí odkaz:
https://doaj.org/article/6fce37aff25441e788d1e7a7cc1e0694
Autor:
Hirotoshi Yasui, Yuko Nishinaga, Shunichi Taki, Kazuomi Takahashi, Yoshitaka Isobe, Misae Shimizu, Chiaki Koike, Tetsuro Taki, Aya Sakamoto, Keiko Katsumi, Keisuke Ishii, Kazuhide Sato
Publikováno v:
EBioMedicine, Vol 67, Iss , Pp 103372- (2021)
Background: GPR87 is a G-protein receptor that is specifically expressed in tumour cells, such as lung cancer, and rarely expressed in normal cells. GPR87 is a promising target for cancer therapy, but its ligand is controversial. Near-infrared photoi
Externí odkaz:
https://doaj.org/article/b6f92625c1f746ff86874407eccfc1eb
Autor:
Yoshitaka Isobe, Kazuhide Sato, Yuko Nishinaga, Kazuomi Takahashi, Shunichi Taki, Hirotoshi Yasui, Misae Shimizu, Rena Endo, Chiaki Koike, Noriko Kuramoto, Hiroshi Yukawa, Shota Nakamura, Takayuki Fukui, Koji Kawaguchi, Toyofumi F. Chen-Yoshikawa, Yoshinobu Baba, Yoshinori Hasegawa
Publikováno v:
EBioMedicine, Vol 52, Iss , Pp - (2020)
Background: Small cell lung cancer (SCLC) has a poor prognosis, and its treatment options are limited. Delta-like protein 3 (DLL3) is expressed specifically in SCLC and is considered a promising therapeutic target for patients with this disease. Rova
Externí odkaz:
https://doaj.org/article/f5b356af007a4eb2ad2ef507bc139ba3
Autor:
Shinichi Miyazaki, Takuya Ikeda, Genshi Ito, Masahide Inoue, Keiji Nara, Yuko Nishinaga, Yoshinori Hasegawa
Publikováno v:
Journal of Medical Case Reports, Vol 11, Iss 1, Pp 1-5 (2017)
Abstract Background Pulmonary tumor thrombotic microangiopathy is a special type of tumor thromboembolism. We report the case of a patient who developed pulmonary tumor thrombotic microangiopathy with alveolar hemorrhage. Almost all patients with pul
Externí odkaz:
https://doaj.org/article/486d1ff7c7c84c0db61e59f6703cd107
Autor:
Yuko Nishinaga, Kazuhide Sato, Hirotoshi Yasui, Shunichi Taki, Kazuomi Takahashi, Misae Shimizu, Rena Endo, Chiaki Koike, Noriko Kuramoto, Shota Nakamura, Takayuki Fukui, Hiroshi Yukawa, Yoshinobu Baba, Mika K. Kaneko, Toyofumi F. Chen-Yoshikawa, Hisataka Kobayashi, Yukinari Kato, Yoshinori Hasegawa
Publikováno v:
Cells, Vol 9, Iss 4, p 1019 (2020)
Malignant pleural mesothelioma (MPM) has extremely limited treatment despite a poor prognosis. Moreover, molecular targeted therapy for MPM has not yet been implemented; thus, a new targeted therapy is highly desirable. Near-infrared photoimmunothera
Externí odkaz:
https://doaj.org/article/f404b554e2c84019be1ed7f1fb222914
Autor:
Tetsuro Taki, Misae Shimizu, Keiko Katsumi, Hirotoshi Yasui, Yoshitaka Isobe, Chiaki Koike, Kazuomi Takahashi, Aya Sakamoto, Keisuke Ishii, Kazuhide Sato, Shunichi Taki, Yuko Nishinaga
Publikováno v:
EBioMedicine
EBioMedicine, Vol 67, Iss, Pp 103372-(2021)
EBioMedicine, Vol 67, Iss, Pp 103372-(2021)
Background: GPR87 is a G protein receptor that is specifically expressed in tumor cells, such as lung cancer, and rarely expressed in normal cells. GPR87 is a promising target for cancer therapy, but its ligand is controversial. Near-infrared photoim
Autor:
Shunichi Taki, Kazuhide Sato, Yuko Nishinaga, Hirotoshi Yasui, Yoshitaka Isobe, Kazuomi Takahashi
Publikováno v:
Journal of Visualized Experiments.
The efficacy of photoimmunotherapy can be evaluated more accurately with an orthotopic mouse model than with a subcutaneous one. A pleural dissemination model can be used for the evaluation of treatment methods for intrathoracic diseases such as lung
Autor:
Mika K. Kaneko, Takayuki Fukui, Shota Nakamura, Shunichi Taki, Misae Shimizu, Hisataka Kobayashi, Yoshinori Hasegawa, Rena Endo, Chiaki Koike, Hirotoshi Yasui, Kazuhide Sato, Toyofumi F. Chen-Yoshikawa, Yoshinobu Baba, Yukinari Kato, Kazuomi Takahashi, Hiroshi Yukawa, Yuko Nishinaga, Noriko Kuramoto
Publikováno v:
Cells, Vol 9, Iss 1019, p 1019 (2020)
Cells
Volume 9
Issue 4
Cells
Volume 9
Issue 4
Malignant pleural mesothelioma (MPM) has extremely limited treatment despite a poor prognosis. Moreover, molecular targeted therapy for MPM has not yet been implemented
thus, a new targeted therapy is highly desirable. Near-infrared photoimmunot
thus, a new targeted therapy is highly desirable. Near-infrared photoimmunot
Autor:
Misae Shimizu, Chiaki Koike, Shunichi Taki, Kazuhide Sato, Yuko Nishinaga, Mitsuo Sato, Hirotoshi Yasui, Kazuomi Takahashi, Kohei Matsuoka
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 11 (2021)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer
BackgroundNear-infrared photoimmunotherapy (NIR-PIT) is a new modality for treating cancer, which uses antibody-photoabsorber (IRDye700DX) conjugates that specifically bind to target tumor cells. This conjugate is then photoactivated by NIR light, in